European Union - English - EMA (European Medicines Agency)

merck sharp & dohme b.v. - human papillomavirus vaccine [types 6, 11, 16, 18, 31, 33, 45, 52, 58] (recombinant, adsorbed) - condylomata acuminata; papillomavirus infections; immunization; uterine cervical dysplasia - papillomavirus vaccines - gardasil 9 is indicated for active immunisation of individuals from the age of 9 years against the following hpv diseases:premalignant lesions and cancers affecting the cervix, vulva, vagina and anus caused by vaccine hpv typesgenital warts (condyloma acuminata) caused by specific hpv types.see sections 4.4 and 5.1 for important information on the data that support these indications.the use of gardasil 9 should be in accordance with official recommendations.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

merck sharp & dohme ltd - human papillomavirus type 6 l1 protein; human papillomavirus type 31 l1 protein; human papillomavirus type 58 l1 protein; human papillomavirus type 52 l1 protein; human papillomavirus type 11 l1 protein; human papillomavirus type 16 l1 protein; human papillomavirus type 18 l1 protein; human papillomavirus type 33 l1 protein; human papillomavirus type 45 l1 protein - suspension for injection

Canada - English - Health Canada

merck canada inc - recombinant human papillomavirus type 6 l1 protein; recombinant human papillomavirus type 11 l1 protein; recombinant human papillomavirus type 16 l1 protein; recombinant human papillomavirus type 18 l1 protein; recombinant human papillomavirus type 31 l1 protein; recombinant human papillomavirus type 33 l1 protein; recombinant human papillomavirus type 45 l1 protein; recombinant human papillomavirus type 52 l1 protein; recombinant human papillomavirus type 58 l1 protein - suspension - 30mcg; 40mcg; 60mcg; 40mcg; 20mcg; 20mcg; 20mcg; 20mcg; 20mcg - recombinant human papillomavirus type 6 l1 protein 30mcg; recombinant human papillomavirus type 11 l1 protein 40mcg; recombinant human papillomavirus type 16 l1 protein 60mcg; recombinant human papillomavirus type 18 l1 protein 40mcg; recombinant human papillomavirus type 31 l1 protein 20mcg; recombinant human papillomavirus type 33 l1 protein 20mcg; recombinant human papillomavirus type 45 l1 protein 20mcg; recombinant human papillomavirus type 52 l1 protein 20mcg; recombinant human papillomavirus type 58 l1 protein 20mcg - vaccines

Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - hpv type 11 l1 protein; hpv type 16 l1 protein; hpv type 18 l1 protein; hpv type 31 l1 protein; hpv type 33 l1 protein; hpv type 45 l1 protein; hpv type 52 l1 protein; hpv type 58 l1 protein; hpv type 6 l1 protein - suspension for injection - hpv type 58 l1 protein 20 mcg / 0.5 ml; hpv type 52 l1 protein 20 mcg / 0.5 ml; hpv type 45 l1 protein 20 mcg / 0.5 ml; hpv type 33 l1 protein 20 mcg / 0.5 ml; hpv type 31 l1 protein 20 mcg / 0.5 ml; hpv type 18 l1 protein 40 mcg / 0.5 ml; hpv type 16 l1 protein 60 mcg / 0.5 ml; hpv type 11 l1 protein 40 mcg / 0.5 ml; hpv type 6 l1 protein 30 mcg / 0.5 ml - papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) - gardasil 9 is indicated for active immunisation of individuals at the age of 9-45 years old against the following hpv diseases:• premalignant lesions and cancers affecting the cervix, vulva, vagina and anus caused by vaccine hpv types• genital warts (condyloma acuminata) caused by specific hpv types.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

merck sharp and dohme llc, united states - human papillomavirus type 6 l1,human papillomavirus type 11 l1,human papillomavirus type 16 l1 protein,human papillomavirus type 18 l1 protein,human papillomavirus type 31 l1 protein,human papillomavirus type 33 l1 protein,human papillomavirus type 45 l1 protein,human papillomavirus type 52 l1 protein,human papillomavirus type 58 l1 protein - suspension for injection - 30,40,60,40,20,20,20,20,20 µg,

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - human papillomavirus type 11 l1 protein; human papillomavirus type 16 l1 protein; human papillomavirus type 18 l1 protein; human papillomavirus type 31 l1 protein; human papillomavirus type 33 l1 protein; human papillomavirus type 45 l1 protein; human papillomavirus type 52 l1 protein; human papillomavirus type 58 l1 protein; human papillomavirus type 6 l1 protein - injection, suspension - human papillomavirus type 11 l1 protein 40 mcg; human papillomavirus type 16 l1 protein 60 mcg; human papillomavirus type 18 l1 protein 40 mcg; human papillomavirus type 31 l1 protein 20 mcg; human papillomavirus type 33 l1 protein 20 mcg; human papillomavirus type 45 l1 protein 20 mcg; human papillomavirus type 52 l1 protein 20 mcg; human papillomavirus type 58 l1 protein 20 mcg; human papillomavirus type 6 l1 protein 30 mcg

Canada - English - Health Canada

merck canada inc - recombinant human papillomavirus type 6 l1 protein; recombinant human papillomavirus type 11 l1 protein; recombinant human papillomavirus type 16 l1 protein; recombinant human papillomavirus type 18 l1 protein - suspension - 20mcg; 40mcg; 40mcg; 20mcg - recombinant human papillomavirus type 6 l1 protein 20mcg; recombinant human papillomavirus type 11 l1 protein 40mcg; recombinant human papillomavirus type 16 l1 protein 40mcg; recombinant human papillomavirus type 18 l1 protein 20mcg - vaccines